Morningstar Aandelenrapport

Johnson & Johnson JNJ

Marges (% van omzet)
20192020202120222023
Inkomsten100,00%100,00%100,00%100,00%100,00%
Kosten van inkomsten33,58%34,42%31,84%32,74%31,18%
Brutomarge 66,42%65,58%68,16%67,26%68,82%
SG&A27,03%26,74%26,30%26,08%25,26%
Research and development13,84%14,72%15,69%16,21%17,71%
Exploitatiemarge 25,55%24,11%26,18%24,97%25,84%
Net Int, Inc and Other46,67%44,09%50,46%47,85%43,53%
EBT-marge21,12%19,98%24,29%22,88%17,69%
Winstgevendheid
20192020202120222023
Belastingtarief2,69%2,16%2,02%3,99%2,04%
Nettomarge18,42%17,82%22,26%18,90%41,28%
Rendement op activa 9,738,8511,709,7119,81
Financiële leverage2,652,762,462,442,44
Rendement op eigen vermogen 25,3623,9730,4123,7948,29
© Copyright 2024 Morningstar, Inc. Alle rechten voorbehouden.

Voorwaarden        Privacybeleid        Cookie Settings        Beleidsdocumenten